StockClub

ANTX

ANTXAN2 Therapeutics, Inc.$ --
AN2 Therapeutics, Inc.

AN2 Therapeutics, Inc.

ANTX

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2026FY2026 Q1
Revenue
0M USD
YoY -
Operating Income
-11M USD
YoY +8.5%
Net Income
-10M USD
YoY +5.8%
EPS
-0.29$
YoY +17.1%

Revenue

$0
FY2024 Q2$0
$0
Q2
FY2024 Q3$0
$0
Q3
FY2024 Q4$0
$0
Q4
FY2025 Q1$0
$0
Q1
FY2025 Q2$0
$0
Q2
FY2025 Q3$0
$0
Q3
FY2025 Q4$0
$0
Q4
FY2026 Q1$0
$0
Q1
Actual
$0 (-)

Net Income

$-10M
FY2024 Q2$-31.1M
$-31.1M
Q2
FY2024 Q3$-43.8M
$-43.8M
Q3
FY2024 Q4$-51.3M
$-51.3M
Q4
FY2025 Q1$-10.6M
$-10.6M
Q1
FY2025 Q2$-17.1M
$-17.1M
Q2
FY2025 Q3$-26.5M
$-26.5M
Q3
FY2025 Q4$-35.2M
$-35.2M
Q4
FY2026 Q1$-10M
$-10M
Q1
Actual
+$621,000 (+5.8%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020
Actual:$0
FY2020
$0
FY2021
Actual:$0
FY2021
$0
FY2022
Actual:$0
FY2022
$0
FY2023
Actual:$0
FY2023
$0
FY2024IN-LINE
Actual:$0
Est:$0
FY2024IN-LINE
$0
FY2025MISS
Actual:$0
Est:$33.2M
FY2025MISS
$0

Analyst Estimates